In vitro activity of tigecycline against molecularly characterised strains of Enterobacteriaceae isolated from phase 3 clinical trials and the Tigecycline Evaluation and Surveillance Trial (TEST)
J Glob Antimicrob Resist
.
2015 Dec;3(4):311-312.
doi: 10.1016/j.jgar.2015.09.004.
Epub 2015 Oct 22.
Authors
Douglas J Biedenbach
1
,
Meredith A Hackel
2
,
Alvaro Quintana
3
,
Michele Wible
3
,
Michael J Dowzicky
3
,
Paul C McGovern
4
,
Samuel K Bouchillon
2
Affiliations
1
International Health Management Associates, Inc., 2122 Palmer Drive, Schaumburg, IL 60173-3817, USA. Electronic address: dbiedenbach@ihmainc.com.
2
International Health Management Associates, Inc., 2122 Palmer Drive, Schaumburg, IL 60173-3817, USA.
3
Pfizer Inc., Collegeville, PA 19426, USA.
4
Actelion, Cherry Hill, NJ 08034, USA.
PMID:
27842883
DOI:
10.1016/j.jgar.2015.09.004
No abstract available
Publication types
Letter